| 5-year survival rate | MFC | Non-MFC | p value |
|---|---|---|---|
| Intrahepatic | 13/22 (59%) | 0/4 (0%) | 0.03 |
| Klatskin | 7/31 (23%) | 14/32 (44%) | 0.07 |
| Mid-duct | 2/2 (100%) | 2/11 (18%) | 0.02 |
| Distal | 3/3 (100%) | 0/2 (0%) | 0.02 |
| 5-year survival rate | MFC | Non-MFC | p value |
|---|---|---|---|
| Intrahepatic | 13/22 (59%) | 0/4 (0%) | 0.03 |
| Klatskin | 7/31 (23%) | 14/32 (44%) | 0.07 |
| Mid-duct | 2/2 (100%) | 2/11 (18%) | 0.02 |
| Distal | 3/3 (100%) | 0/2 (0%) | 0.02 |